has been cited by the following article(s):
[1]
|
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
Journal of Medical Case Reports,
2018
DOI:10.1186/s13256-017-1550-6
|
|
|